Literature DB >> 3147138

Therapeutic roles of intracavernosal papaverine.

I Goldstein1, T Payton, H Padma-Nathan.   

Abstract

Intracavernosal self-injection of smooth muscle relaxants, primarily papaverine admixed with phentolamine, have been used to treat impotence in over 300 patients. The program is effective in a large fraction of this group. Selection of patients, adjustment of dose, methods for monitoring, clinical efficacy, and complications are discussed.

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3147138     DOI： 10.1007/bf02577009

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN： 0174-1551            Impact factor:   2.740


  3 in total

1.  Auto-injection of the corpus cavernosum with a vasoactive drug combination for vasculogenic impotence.

Authors:  A W Zorgniotti; R S Lefleur
Journal:  J Urol       Date:  1985-01       Impact factor: 7.450

2.  Intracavernous drug-induced erections in the management of male erectile dysfunction: experience with 100 patients.

Authors:  A A Sidi; J S Cameron; L M Duffy; P H Lange
Journal:  J Urol       Date:  1986-04       Impact factor: 7.450

3.  Intracavernous injection of papaverine for erectile failure.

Authors:  R Virag
Journal:  Lancet       Date:  1982-10-23       Impact factor: 79.321
  3 in total
  2 in total

1.  Pharmacoangiographic assessment of the corpora cavernosa.

Authors:  J J Bookstein; B Fellmeth; S Moreland; A L Lurie
Journal:  Cardiovasc Intervent Radiol       Date:  1988-08       Impact factor: 2.740

Review 2.  The treatment of erectile dysfunction in patients with neurogenic disease.

Authors:  Anand N Shridharani; William O Brant
Journal:  Transl Androl Urol       Date:  2016-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.